A TRIAL OF TWO DACLIZUMAB DOSING STRATEGIES VS. NO INDUCTION TREATMENT WITH TACROLIMUS, MYCOPHENOLATE MOFETIL , & STEROIDS FOR THE PREVENTION OF ACUTE ALLOGRAFT REJECTION IN SIMULTANEOUS KIDNEY/PANCREAS TRANSPLANT RECIPIENTS: